|| Print ||
|Friday, June 18, 2010|
The Oregon Board of Pharmacy announced Thursday that it would remove marijuana from the list of “Schedule I Controlled Substances” to a schedule II classification – meaning the board recognizes that marijuana does have an acceptable medical use. Oregon is the first state in the nation to take such a step, contradicting the federal government's stance on marijuana. But advocates still are disappointed and plan to appeal.
“The classification itself shows that medical marijuana patients are still being discriminated against because [marijuana] is still classified with substances like oxycodone, which is one very small step from heroin,” said attorney Gregory Barton, who plans to appeal the decision. “[Schedule II] drugs have caused deaths whereas marijuana is basically a non-toxic herb that hasn’t ever caused any deaths.”
The reclassification comes after Senate Bill 728 passed last year, which required marijuana to be removed from the schedule I list and reclassified. Over the last several months the board listened to testimony and research from advocates and law enforcement officers concerned about abuse before voting on the reclassification.
The federal government treats marijuana as a non-medicinal Schedule I drug, but more than a dozen states including Oregon allow medical marijuana use. In addition, the regulators in the United Kingdom have approved the first-ever prescription medication derived from the cannabis plant, an MS drug called Sativex. The medication went on sale for the first time today in England.
Schedule I drugs, such as LSD and heroin, typically have no medicinal value and high abuse potential. Marijuana was moved into the schedule II substances, which are said to have “high abuse potential with severe psychological or physical dependence liability but are accepted for medical use in the US and are available by prescription,” according to the press release.
Barton is filing the appeal on the basis that the board didn’t consider the proper factors in its decision making process. “They really ended up ignoring a lot of the scientific evidence and eventually just listened to the political pressures to make it a schedule II.”
Christine McGarvin is a medical marijuana advocate who testified several months ago about the reclassification, and like many other supporters she is disgruntled by the decision.
“We don’t think medical marijuana should be classified any higher than a schedule III at least” said McGarvin. “There is a big difference between schedule II and schedule III in terms of a felony or misdemeanor according to the law.”
For a schedule II classification anyone who is not in compliance with the Oregon Medical Marijuana Act (OMMA), and possesses more than an once is immediately charged with a felony. Possessing less than an ounce of marijuana is treated as a minor violation similar to a traffic ticket under state law.
Both McGarvin and Barton cited discrepancies about where Marinol and marijuana are classified. Marinol is a purified form of THC and it’s a pharmaceutical product, but it's a schedule III classification. Marinol is already widely available through prescription. According to Barton a less purified form of a substance and the pure form is almost always scheduled in either the same or lower classification, and marijuana and Marinol are the only exceptions. He argues marijuana should at least be scheduled with Marinol, a synthetic form of THC, in the schedule III classification or lower.
This new classification won’t change anything for Initiative 28, which would allow nonprofit dispensaries to sell medical marijuana to patients and enable licensed growers to sell to dispensaries. I-28 already has accumulated an estimated 115,000 signatures, and will likely make it to the November ballot ballot.
Anthony Johnson, chief petitioner for the initiative, said the reclassification doesn’t change anything as a practical matter because the medical marijuana dispensaries would be regulated by the Department of Human Services and not the Oregon Board of Pharmacy.
“As a symbolic victory it does establish the fact that cannabis has a medicinal value and so it may help convince people that sick and disabled patients should have that option and that will convince more people to support the initiative,” said Johnson.
So the controversy continues. Read more about how pot could and already does bring economic development to Oregon as Ben Jacklet reports in “Marijuana Goes Mainstream” from the May 2010 issue of Oregon Business Magazine.
Jessica Hoch is an online reporter for Oregon Business.
|OHSU researchers work on AIDS vaccine|
|Lean in? Not Sabrina Parsons.|
|Oregon agriculture - not just a commodity|
|The cable guy|
|Outside the box|
|Pope Francis is TIME's Person of the Year|
|UK says cure for dementia possible by 2025|
|Budget deal reached in Congress|
|Mars freshwater lake might have supported life|
|Uruguay to become first country to legalize marijuana|
|GM names first woman CEO|
|Government spies snooped in video games|
Produced by the Oregon Business marketing department
When the Portland-based manufacturing company Glass Alchemy, Ltd. was first nominated for an Oregon State University Austin Family Business Excellence in Family Business award in 2004, husband-and-wife team Henry Grimmett and Susan Webb-Grimmett, were honored and optimistic about their chances of winning.
Some employers have embraced the use of employment arbitration agreements as a way to manage and mitigate the rising costs, risks and liabilities associated with employment-related claims. Historically, employment arbitration agreements require employees to present employment-related claims, such as employment discrimination, wrongful discharge, harassment, or claims for wages or compensation to an arbitrator, in lieu of proceeding to court.
Produced by the Oregon Business marketing department
Boly:Welch was founded in 1986 based on a close connection between Diane Boly and Pat Welch. The two had worked together at another recruitment firm and shared certain core values: passion for their work, a sense of humor, a commitment to their community and a desire to create a healthy, nurturing work environment.
The Oregon New Lawyers Division of the Oregon State Bar recognized two of Barran Liebman’s own at their Annual Meeting and Social on November 1.
Barran Liebman LLP is proud to announce that Iris Tilley has been named a partner with the firm. Iris has been with Barran Liebman since 2009 and is a member of the Employee Benefits practice group. She advises employers in all aspects of employee benefits, including ERISA, COBRA, HIPAA, retirement plans, compensation agreements, and health care reform.
Dunn Carney will host its annual Ag Summit on Jan. 10, 2014 at the Holiday Inn in Wilsonville, OR. We are very pleased to welcome Dr. Sherri Noxel, Director of the Austin Family Business Program at Oregon State University College of Business as our Keynote speaker.